Cytek Biosciences Achieves 40-Color Panel from a Single Sample with New Flow System
The cytometry system is available with up to five lasers to analyze up to 40 markers in one sample.
Cytek Biosciences, a flow cytometry instrumentation provider based in Fremont, CA, has developed and demonstrated a high-quality 40-color panel from a single sample using the Cytek Aurora advanced flow cytometry system.
The device uses various patent-pending technologies and allows users to combine their markers in one sample and achieve high resolution for each individual marker, according to a Sept. 25, 2019 press release. The cytometry system is available with up to five lasers to analyze up to 40 markers in one sample and provides users with flexible dye choices, the power to extract sample autofluorescence, intuitive workflows, and the ability to extract multiplexed high-quality data from a single test.
“As the flow cytometry market continues to expand rapidly and reach an estimated $8.92 billion globally by 2026, we fully expect that the Aurora will become a large, powerful, and capable presence in the market,” said Dr. Wenbin Jiang, CEO of Cytek Biosciences, in the press release. “We are committed to addressing the lack of access to advanced scientific instrumentation and giving scientists the tools they need to take their fields to the next level. High-quality 40-color data makes in-depth insights and statistically powerful numbers from rare sample populations possible-and accelerates the pace of scientific discovery.”
Source: Cytek Biosciences
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
